Savara Ownership | Who Owns Savara?
Savara Ownership Summary
Savara is owned by 75.76% institutional investors, 4.59% insiders, and 19.64% retail investors. Nea management company is the largest institutional shareholder, holding 13.41% of SVRA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.89% of its assets in Savara shares.
SVRA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Savara | 75.76% | 4.59% | 19.64% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Nea management company | 24.47M | 13.41% | $98.62M |
Bain capital life sciences investors | 14.57M | 7.98% | $58.70M |
Tcg crossover management | 12.36M | 6.77% | $49.82M |
Frazier life sciences management | 8.16M | 4.47% | $32.87M |
Blackrock | 8.03M | 4.40% | $32.36M |
Wellington management group llp | 7.02M | 3.84% | $28.27M |
Adage capital partners gp | 6.99M | 3.83% | $28.16M |
Vanguard group | 6.64M | 3.64% | $26.75M |
Vestal point capital, lp | 6.49M | 3.56% | $26.15M |
Jennison associates | 5.73M | 3.14% | $23.10M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Nea management company | 24.47M | 7.42% | $98.62M |
Bain capital life sciences investors | 14.57M | 6.44% | $58.70M |
Tcg crossover management | 12.36M | 5.19% | $49.82M |
Vestal point capital, lp | 6.49M | 1.95% | $26.15M |
Frazier life sciences management | 8.16M | 1.54% | $32.87M |
Ghost tree capital | 1.05M | 1.33% | $4.24M |
Nantahala capital management | 5.18M | 1.22% | $20.88M |
Superstring capital management lp | 200.00K | 1.02% | $806.00K |
Affinity asset advisors | 1.55M | 0.72% | $6.23M |
Sphera funds management | 962.69K | 0.53% | $3.88M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Vestal point capital, lp | 6.49M | 1.95% | 6.49M |
Wellington management group llp | 7.02M | 0.01% | 4.24M |
Frazier life sciences management | 8.16M | 1.54% | 4.16M |
Nantahala capital management | 5.18M | 1.22% | 3.44M |
Tcg crossover management | 12.36M | 5.19% | 2.36M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Jennison associates | 5.73M | 0.01% | -3.11M |
Vivo capital | - | - | -2.09M |
First light asset management | - | - | -2.00M |
Superstring capital management lp | 200.00K | 1.02% | -1.87M |
Adage capital partners gp | 6.99M | 0.05% | -1.30M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Vestal point capital, lp | 6.49M | 1.95% | 6.49M | $26.15M |
Sphera funds management | 962.69K | 0.53% | 962.69K | $3.88M |
Sofinnova investments | 150.00K | 0.03% | 150.00K | $604.50K |
Rafferty asset management | 135.64K | 0.00% | 135.64K | $546.63K |
Victory capital management | 130.83K | 0.00% | 130.83K | $527.25K |
Sold Out
Holder | Change |
---|---|
Federated hermes | -1.00 |
Nelson, van denburg & campbell wealth management group | -16.00 |
Signaturefd | -30.00 |
Gamma investing | -60.00 |
Quadrant capital group | -218.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 128 | -11.72% | 160,502,555 | 8.32% | 75 | 1.15% | 74 | -15.91% | 26 | -10.34% |
Jun 30, 2024 | 145 | 16.94% | 148,180,451 | 22.39% | 81 | 1.85% | 88 | 8.64% | 29 | 26.09% |
Mar 31, 2024 | 124 | 25.25% | 121,071,741 | 1.76% | 66 | 1.28% | 81 | 39.66% | 23 | 21.05% |
Dec 31, 2023 | 99 | 15.12% | 118,973,093 | 1.92% | 72 | 1.43% | 58 | 3.57% | 19 | 11.76% |
Sep 30, 2023 | 86 | 10.26% | 116,727,670 | 31.02% | 71 | 2.09% | 56 | 19.15% | 17 | 6.25% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 4.94M | 2.89% | 7.36K |
Jennison Health Sciences Equity | 3.78M | 2.29% | 463.66K |
PGIM Jennison Health Sciences Z | 3.78M | 2.21% | - |
iShares Russell 2000 ETF | 2.97M | 1.80% | -6.68K |
SPDR® S&P Biotech ETF | 1.85M | 1.13% | 20.53K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.54M | 0.90% | -7.65K |
UTM IM GBP AXA Framlington Biotech | 1.01M | 0.61% | - |
Fidelity Small Cap Index | 993.74K | 0.60% | -24.63K |
Fidelity Advisor Biotechnology I | 986.50K | 0.60% | - |
iShares Russell 2000 Growth ETF | 852.02K | 0.52% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 16, 2024 | Lowrance David L | Chief Financial Officer | Sell | $83.28K |
Dec 16, 2024 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Sell | $180.83K |
Dec 16, 2024 | Hawkins Richard J | - | Sell | $26.57K |
Nov 19, 2024 | McCracken Joseph S | - | Buy | $59.07K |
Nov 18, 2024 | RAMSAY DAVID A | - | Buy | $287.60K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | 2 | 3 |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | - | 3 |
SVRA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools